Co-treatment with TNF-α and DEX effectively blocked TNF-α-induced apoptosis by inhibiting XIAP, c-IAP1, and c-IAP2 cleavage in human breast cancer cells (MCF-7) [9]. The gene discussed is BIRC2; the disease is breast carcinoma.